Physicochemical characterization of naproxen solid dispersions prepared via spray drying technology

Powder Technology

Volumn 246, Issue , 2013, Pages 448-455

  Adibkia, Khosro ^a,b   Barzegar Jalali, Mohammad ^a,b   Maheri Esfanjani, Hosein ^b   Ghanbarzadeh, Saeed ^b   Shokri, Javad ^b   Sabzevari, Araz ^c   Javadzadeh, Yousef ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Naproxen; Physicochemical characterization; Release rate; Solid dispersion; Spray drying

Indexed keywords

FOURIER TRANSFORM INFRA RED (FTIR) SPECTROSCOPY; NAPROXENS; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PHYSICO-CHEMICAL CHARACTERIZATION; PHYSICOCHEMICAL PROPERTY; RELEASE RATE; SOLID DISPERSION; SPRAY DRYING TECHNOLOGY;

BIOCHEMISTRY; CHARACTERIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MIXTURES; PARTICLE SIZE; POLYMERS; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; X RAY DIFFRACTION; X RAY DIFFRACTION ANALYSIS;

SUSPENSIONS (FLUIDS);

CROSPOVIDONE; HYDROXYPROPYLMETHYLCELLULOSE; NAPROXEN; WATER;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; INFRARED SPECTROSCOPY; INTESTINE FLUID; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SIMULATION; SPRAY DRYING; STOMACH JUICE; X RAY DIFFRACTION;

EID: 84879736298     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2013.05.044     Document Type: Article

References (41)

1. Bettinetti G.P., Sorrenti M., Rossi S., Ferrari F., Mura P., Faucci M.T. Assessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSC. J. Pharm. Biomed. Anal. 2002, 30(4):1173-1179.
2. Correa M.A., Scarpa M.V., Franzini M.C., Oliveira A.G. On the incorporation of the non-steroidal anti-inflammatory naproxen into cationic O/W microemulsions. Colloids Surf., B 2005, 43(2):108-114.
3. Guo Z., Liu X.-M., Ma L., Li J., Zhang H., Gao Y.-P., Yuan Y. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement. Colloids Surf., B 2010, 101(1):228-235.
4. Joiris E., Martino P.D., Malaj L., Censi R., Barthmy C., Odou P. Influence of crystal hydration on the mechanical properties of sodium naproxen. Eur. J. Pharm. Biopharm. 2008, 70(1):345-356.
5. Maghsoodi M., Taghizadeh O., Martin G.P., Nokhodchi A. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique. Int. J. Pharm. 2008, 351(1/2):45-54.
6. Elder D.P., Holm R., Diego H.L.d. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility. Int. J. Pharm. 2013, 0. (In Press, Corrected proof).
7. Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50(1):47-60.
8. Mutalik S., Anju P., Manoj K., Usha A.N. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach. Int. J. Pharm. 2008, 350(1/2):279-290.
9. Zisiou E.-P., Pinto P.C.A.G., Saraiva M.c.M.F.S., Siquet C., Lima J.L.F.C. Sensitive sequential injection determination of naproxen based on interaction with cyclodextrin. Talanta 2005, 68(2):226-230.
10. Maestrelli F., Zerrouk N., Chemtob C., Mura P. Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells. Int. J. Pharm. 2004, 271(1/2):257-267.
11. Tantishaiyakul V., Kaewnopparat N., Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int. J. Pharm. 1999, 181(2):143-151.
12. Valero M., Prez-Revuelta B.I., Roguez L.J. Effect of PVP K-25 on the formation of the naproxen ciclodextrin complex. Int. J. Pharm. 2003, 253(1/2):97-110.
13. Weuts I., Kempen D., Verreck G., Decorte A., Heymans K., Peeters J., Brewster M., Mooter G.V.d. Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying. Eur. J. Pharm. Biopharm. 2005, 59(1):119-126.
14. Zahedi P., Lee P.I. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels. Eur. J. Pharm. Biopharm. 2007, 65(3):320-328.
15. Barzegar-Jalali M., Adibkia K., Valizadeh H., Siahi-Shadbad M.R., Nokhodchi A., Omidi Y., Mohammadi G., Hallaj-Nezhadi S., Hasan M. Kinetic analysis of drug release from nanoparticles. J. Pharm. Pharm. Sci. 2008, 11(1):167-177.
16. Barzegar-Jalali M., Alaei-Beirami M., Javadzadeh Y., Mohammadi G., Hamidi A., Andalib S., Adibkia K. Comparison of physicochemical characteristics and drug release of diclofenac sodium-eudragit® RS100 nanoparticles and solid dispersions. Powder Technol. 2012, 219:211-216.
17. Valizadeh H., Zakeri-Milani P., Barzegar-Jalali M., Mohammadi G., Danesh-Bahreini M.A., Adibkia K., Nokhodchi A. Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev. Ind. Pharm. 2007, 33(1):45-56.
18. Baird J.A., Taylor L.S. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv. Drug Delivery Rev. 2010, 64(5):396-421.
19. Cafaggi S., Russo E., Caviglioli G., Parodi B., Stefani R., Sillo G., Leardi R., Bignardi G. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation. Eur. J. Pharm. Sci. 2008, 35(1/2):19-29.
20. Mura P., Faucci M.T., Bettinetti G.P. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-cyclodextrin. Eur. J. Pharm. Sci. 2001, 13(2):187-194.
21. Zerrouk N., Mennini N., Maestrelli F., Chemtob C., Mura P. Comparison of the effect of chitosan and polyvinylpyrrolidone on dissolution properties and analgesic effect of naproxen. Eur. J. Pharm. Biopharm. 2004, 57(1):93-99.
22. Barzegar-Jalali M., Nayebi A.M., Valizadeh H., Hanaee J., Barzegar-Jalali A., Adibkia K., Anoush M., Sistanizad M. Evaluation of in vitro-in vivo correlation and anticonvulsive effect of carbamazepine after cogrinding with microcrystalline cellulose. J. Pharm. Pharm. Sci. 2006, 9(3):307-316.
23. Barzegar-Jalali M., Valizadeh H., Siahi-Shadbad M.R., Adibkia K., Mohammadi G., Farahani A., Arash Z., Nokhodchi A. Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide). Powder Technol. 2010, 197(3):150-158.
24. Javadzadeh Y., Ahadi F., Davaran S., Mohammadi G., Sabzevari A., Adibkia K. Preparation and physicochemical characterization of naproxen-PLGA nanoparticles. Colloids Surf., B 2010, 81(2):498-502.
25. Chauhan B., Shimpi S., Paradkar A. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur. J. Pharm. Sci. 2005, 26(2):219-230.
26. Paudel A., Worku Z.A., Meeus J., Guns S., Van den Mooter G. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: Formulation and process considerations. Int. J. Pharm. 2013, 0. (In Press, Corrected Proof).
27. The United States Pharmacopeia 34:The National Formulary 29 2011, The United States Pharmacopeial Convention, Inc., Rockville.
28. Mohammadi G., Barzegar-Jalali M., Valizadeh H., Nazemiyeh H., Barzegar-Jalali A., Siahi-Shadbad M.R., Adibkia K., Zare M. Reciprocal powered time model for release kinetic analysis of ibuprofen solid dispersions in oleaster powder, microcrystalline cellulose and crospovidone. J. Pharm. Pharm. Sci. 2010, 13(2):152-161.
29. Li Y., Chow P.S., Tan R.B.H. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy. Int. J. Pharm. 2011, 415(1-2):110-118.
30. McGregor C., Bines E. The use of high-speed differential scanning calorimetry (Hyper-DSC™) in the study of pharmaceutical polymorphs. Int. J. Pharm. 2008, 350(1-2):48-52.
31. Oguchi T., Sasaki N., Hara T., Tozuka Y., Yamamoto K. Differentiated thermal crystallization from amorphous chenodeoxycholic acid between the ground specimens derived from the polymorphs. Int. J. Pharm. 2003, 253(1-2):81-88.
32. Xu L., Wang J., Xiao B., Yang J., Liu Y., Huang R. Preparation and characterization of a novel polymorph of indiplon, Form α. Bioorg. Med. Chem. Lett. 2012, 22(2):963-968.
33. Tiong N., Elkordy A.A. Effects of liquisolid formulations on dissolution of naproxen. Eur. J. Pharm. Biopharm. 2009, 73(3):373-384.
34. Vasconcelos T., Sarmento B., Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today 2007, 12(23/24):1068-1075.
35. Morissette S.L., Almarsson Ö., Peterson M.L., Remenar J.F., Read M.J., Lemmo A.V., Ellis S., Cima M.J., Gardner C.R. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv. Drug Delivery Rev. 2004, 56(3):275-300.
36. Torrado G., Fraile S., Torrado S., Torrado S. Process-induced crystallite size and dissolution changes elucidated by a variety of analytical methods. Int. J. Pharm. 1998, 166(1):55-63.
37. Fakes M.G., Vakkalagadda B.J., Qian F., Desikan S., Gandhi R.B., Lai C., Hsieh A., Franchini M.K., Toale H., Brown J. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches. Int. J. Pharm. 2009, 370(1/2):167-174.
38. Kiortsis S., Kachrimanis K., Broussali T., Malamataris S. Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component. Eur. J. Pharm. Biopharm. 2005, 59(1):73-83.
39. Devjak Novak S., Šporar E., Baumgartner S., Vrečer F. Characterization of physicochemical properties of hydroxypropyl methylcellulose (HPMC) type 2208 and their influence on prolonged drug release from matrix tablets. J. Pharm. Biomed. Anal. 2012, 66:136-143.
40. Papadopoulou V., Kosmidis K., Vlachou M., Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int. J. Pharm. 2006, 309(1-2):44-50.
41. Adibkia K., Siahi-Shadbad M.R., Nokhodchi A., Javadzedeh A., Barzegar-Jalali M., Barar J., Mohammadi G., Omidi Y. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis. J. Drug Target. 2007, 15(6):407-416.